Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: ResMed, Inc.

Market Cap 26.9B 23.21B 21.34B 20.09B 37.74B 2,539B 38.06B 253B 98.45B 1,246B 101B 98.82B 4,311B P/E 2026 *
17.6x
P/E 2027 * 15.9x
Enterprise Value 26.05B 22.47B 20.66B 19.44B 36.54B 2,458B 36.84B 245B 95.31B 1,206B 97.75B 95.66B 4,173B EV / Sales 2026 *
4.61x
EV / Sales 2027 * 4.15x
Free-Float
75.61%
Yield 2026 *
1.3%
Yield 2027 * 1.44%
1 day+1.70%
1 week-1.67%
Current month-0.73%
1 month-7.33%
3 months-16.98%
6 months-22.00%
Current year-21.46%
1 week 184.65
Extreme 184.65
197.41
1 month 180.26
Extreme 180.265
211.74
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
06-08Fiscal year

Chief Executive Officer

14,973 0.0103%
06-01Tax

General Counsel

-269 0.0002%
05-07Fiscal year

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+1.59%-1.67%-24.59%-12.74% 26.9B
+0.26%-2.59%+18.03%-12.14% 172B
+0.86%-1.62%-20.27%+23.91% 142B
+0.02%-1.67%-8.57%-24.86% 126B
+1.01%-3.85%-55.26%-16.07% 66.81B
+0.89%+1.77%+17.98%-5.04% 49.91B
-1.14%-0.41%-24.77%-34.59% 44.81B
+1.81%-2.26%+9.61%+7.16% 35.11B
-0.50%-1.20%+4.73%+35.00% 35.05B
+1.07%-4.25%-14.08%-21.71% 27.82B
Average +0.58%-3.21%-9.72%-6.11% 72.62B
Weighted average by Cap. +0.47%-3.32%-7.33%-5.71%

Financials

2026 *2027 *
Net sales 5.65B 4.88B 4.48B 4.22B 7.93B 533B 7.99B 53.12B 20.68B 262B 21.21B 20.76B 905B 6.1B 5.26B 4.84B 4.55B 8.55B 575B 8.62B 57.3B 22.31B 282B 22.88B 22.39B 977B
Net income 1.55B 1.34B 1.23B 1.16B 2.17B 146B 2.19B 14.56B 5.67B 71.73B 5.81B 5.69B 248B 1.7B 1.47B 1.35B 1.27B 2.39B 160B 2.41B 15.98B 6.22B 78.77B 6.38B 6.25B 272B
Net Debt -859M -741M -681M -641M -1.21B -81.08B -1.22B -8.08B -3.14B -39.79B -3.22B -3.16B -138B -1.58B -1.36B -1.25B -1.18B -2.21B -149B -2.23B -14.83B -5.77B -73.07B -5.92B -5.79B -253B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
18/06/26 187.42 $ +0.61% 900,681
17/06/26 186.29 $ -3.94% 1,873,182
16/06/26 193.94 $ +0.62% 1,092,000
15/06/26 192.74 $ -1.05% 1,523,766
12/06/26 194.78 $ +1.24% 1,085,732
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
186.29USD
Average target price
262.20USD
Spread / Average Target
+40.75%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!